Subscribe to RSS
DOI: 10.1055/s-0037-1615763
Evidence for a Role for Phospholipase C, but not Phospholipase A2, in Platelet Activation in Response to Low Concentrations of Collagen
Publication History
Received
11 September 2000
Accepted after resubmission
05 December 2000
Publication Date:
11 December 2017 (online)
Summary
The release of arachidonic acid is a key component in platelet activation in response to low concentrations (1-20 g/ml) of collagen. The precise mechanism remains elusive although a variety of pathways have been implicated. In the present study the effects of inhibitors of several potentially key enzymes in these pathways have been examined. Collagen (1-10 g/ml) caused maximal platelet aggregation which was accompanied by the release of arachidonic acid, the synthesis of thromboxane A2, and p38MAPK phosphorylation. Preincubation with the dual cyclooxygenase/lipoxygenase inhibitor BW755C inhibited aggregation and thromboxane production, and reduced p38MAPK phosphorylation. A phospholipase C inhibitor, U73122, blocked collagen-induced aggregation and reduced arachidonic acid release, thromboxane synthesis and p38MAPK phosphorylation. Pretreatment with a cytosolic phospholipase A2 inhibitor, AACOCF3, blocked collagen-induced aggregation, reduced the levels of thromboxane formation and p38MAPK phosphorylation but had no significant effect on arachidonic acid release. In contrast inhibition of PKC by Rö31-8220 inhibited collagen-induced aggregation, did not affect p38MAPK phosphorylation but significantly potentiated arachidonic acid release and thromboxane formation. Collagen caused the tyrosine phosphorylation of phospholipase C 2 which was inhibited by pretreatment with U73122, unaffected by AACOCF3 and enhanced by Rö31-8220. These results suggest that cytosolic phospholipase A2 plays no role in the arachidonic acid release in response to collagen. In contrast, the data are consistent with phospholipase C 2 playing a role in an intricately controlled pathway, or multiple pathways, mediating the release of arachidonic acid in collagen-stimulated platelets.
-
References
- 1 Sixma JJ, van Zanten GH, Huizinga EG, van der Plas RM, Verkley M, Wu YP, Gros P, de Groot PG. Platelet adhesion to collagen: an update. Thromb Haemost 1997; 78: 434-38.
- 2 Moroi M, Jung SM. Platelet receptors for collagen. Thromb Haemost 1997; 78: 439-44.
- 3 Watson SP. Collagen receptor signaling platelets and megakaryocytes. Thromb Haemost 1999; 82: 365-76.
- 4 Watson SP, Gibbins J. Collagen receptor signaling in platelets: extending the role of the ITAM. Immunol Today 1998; 19: 260-4.
- 5 Ezumi Y, Shindoh K, Tsuji M, Takayama H. Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets. J Exp Med 1998; 188: 267-76.
- 6 Briddon SJ, Watson SP. Evidence for the involvement of p59fyn and p53/56lyn in collagen receptor signalling in human platelets. Biochem J 1999; 338: 203-9.
- 7 Gibbins J, Asselin J, Farndale R, Barnes M, Law CL, Watson SP. Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J Biol Chem 1996; 271: 18095-9.
- 8 Gibbins JM, Okuma M, Farndale R, Barnes M, Watson SP. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain. FEBS Lett 1997; 413: 255-9.
- 9 Tsuji M, Ezumi Y, Arai M, Takayama H. A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem 1997; 272: 23528-31.
- 10 Yanaga F, Poole A, Asselin J, Blake R, Schieven GL, Clark EA, Law CL, Watson SP. Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor. Biochem J 1995; 311: 471-8.
- 11 Ichinohe T, Takayama H, Ezumi Y, Arai M, Yamamoto N, Takahashi H, Okuma M. Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem 1997; 272: 63-8.
- 12 Asselin J, Gibbins JM, Achison M, Lee YH, Morton LF, Farndale RW, Barnes MJ, Watson SP. A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C gamma2 in platelets independent of the integrin alpha2beta1. Blood 1997; 89: 1235-42.
- 13 Blake RA, Schieven GL, Watson SP. Collagen stimulates tyrosine phosphorylation of phospholipase C-gamma2 but not phospholipase C-gamma 1 in human platelets. FEBS Lett 1994; 353: 212-6.
- 14 Daniel JL, Dangelmaier C, Smith JB. Evidence for a role for tyrosine phosphorylation of phospholipase C gamma2 in collagen-induced platelet cytosolic calcium mobilization. Biochem J 1994; 302: 617-22.
- 15 Gibbins JM, Briddon S, Shutes A, van Vugt MJ, van de Winkel JG, Saito T, Watson SP. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor gamma-chain and linker for activitor of T cells (LAT) in platelets stimulated by collagen and convulxin. J Biol Chem 1998; 273: 34437-43.
- 16 Oda A, Ochs HD, Druker BJ, Ozaki K, Watanabe C, Handa M, Miyakawa Y, Ikeda Y. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets. Blood 1998; 92: 1852-8.
- 17 Quek LS, Bolen J, Watson SP. A role for Bruton’s tyrosine kinase (Btk) in platelet activation by collagen. Curr Biol 1998; 8: 1137-40.
- 18 Gross BS, Lee JR, Clements JL, Turner M, Tybulewicz VL, Findell PR, Koretzky GA, Watson SP. Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets. J Biol Chem 1999; 274: 5963-71.
- 19 Asazuma N, Wilde JI, Berlanga O, Leduc M, Leo A, Schweighoffer E, Tybulewicz V, Bon C, Liu SK, McGlade CJ, Schraven B, Watson SP. Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin. J Biol Chem 2000; 275: 33427-34.
- 20 Pasquet JM, Bobe R, Gross B, Gratacap MP, Tomlinson MG, Payrastre B, Watson SP. A collagen-related peptide regulates phospholipase Cgamma2 via phosphatidylinositol 3-kinase in human platelets. Biochem J 1999; 342: 171-7.
- 21 Pasquet JM, Quek L, Stevens C, Bobe R, Huber M, Duronio V, Krystal G, Watson SP. Phosphatidylinositol 3,4,5-trisphosphate regulates Ca(2+) entry via btk in platelets and megakaryocytes without increasing phospholipase C activity. EMBO J 2000; 19: 2793-802.
- 22 Keely PJ, Parise LV. The alpha2beta1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cgamma2 in platelets. J Biol Chem 1996; 271: 26668-76.
- 23 Watson SP, Reep B, McConnell RT, Lapetina EG. Collagen stimulates [3H) inositol trisphosphate formation in indomethacin-treated human platelets. Biochem J 1985; 226: 831-7.
- 24 Smith JB, Selak MA, Dangelmaier C, Daniel JL. Cytosolic calcium as a second messenger for collagen-induced platelet responses. Biochem J 1992; 288: 925-9.
- 25 Börsch-Haubold AG, Kramer RM, Watson SP. Cytosolic phospholipase A 2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J Biol Chem 1995; 270: 25885-92.
- 26 Börsch-Haubold AG, Kramer RM, Watson SP. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem 1997; 245: 751-9.
- 27 Narita H, Park HJ, Tanaka K, Matsuura T, Kito M. Insufficient mobilization of calcium by early breakdown of phosphatidylinositol 4,5-bisphosphate for aggregation of human platelets by collagen. J Biochem (Tokyo) 1985; 98: 1063-8.
- 28 Pollock WK, Rink TJ, Irvine RF. Liberation of [3H]-arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen. Biochem J 1986; 235: 869-77.
- 29 Kito M, Narita H, Takamura H, Park HJ, Matsuura T, Tanaka K. Dissociation of Ca2+ mobilization from breakdown of phosphatidylinositol 4,5-bisphosphate in activated human platelets. J Biochem (Tokyo) 1986; 99: 1277-80.
- 30 Seymour RA, Williams FM, Oxley A, Ward A, Fearns M, Brighan K, Rawlins MD, Jones PM. A comparative study of the effects of aspirin and paracetamol (acetaminophen) on platelet aggregation and bleeding time. Eur J Clin Pharmacol 1984; 26: 567-71.
- 31 Gerrard JM, Docherty JC, Israels SJ, Cheang MS, Bishop AJ, Kobrinsky NL, Schroeder ML, Israels ED. A reassessment of the bleeding time: association of age, hematocrit platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time. Clin Invest Med 1989; 12: 165-71.
- 32 McNicol A, Saxena SP, Becker AB, Brandes LJ, Gerrard JM. Further studies on the effects of the intracellular histamine antagonist DPPE on platelet function. Platelets 1991; 2: 215-21.
- 33 Scrutton MC. The platelet as a Ca2+-driven cell: Mechanisms which may modulate Ca2+-driven responses. Adv Exp Med Biol 1993; 344: 1-15.
- 34 Thomas LM, Holub BJ. BW755C or staurosporine inhibits collagen-stimulated phospho-inositide phosphorylation in platelets. Lipids 1991; 26: 689-95.
- 35 Saklatvala J, Rawlinson L, Waller RJ, Sarsfield S, Lee JC, Morton LF, Barnes MJ, Farndale RW. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 1996; 271: 6586-9.
- 36 Barnes MJ, Knight CG, Farndale RW. The collagen-platelet interaction. Curr Opin Hematol 1998; 5: 314-20.
- 37 Karniguian A, Grelac F, Levy-Toledano S, Legrand YJ, Rendu F. Collagen-induced platelet activation mainly involves the protein kinase C pathway. Biochem J 1990; 268: 325-31.
- 38 McNicol A. Platelet preparation and estimation of functional responses. In: Platelets: A Practical Approach. Watson SP, Authi KS. eds. Oxford: Oxford University Press; 1996: 1-26.
- 39 Dole VP, Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissue. J Biol Chem 1960; 235: 2595-9.
- 40 Püttmann M, Krug H, van Ochsenstein E, Kattermann R. Fast HPLC determination of serum free fatty acids in the picomole range. Clin Chem 1993; 39: 825-32.
- 41 Pampolina C, McNicol A. Anisomycin does not activate p38MAPK in human platelets. Thromb Res 1999; 96: 27-35.
- 42 Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 1990; 255: 756-68.
- 43 Lockhart LK, McNicol A. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. J Pharmacol Exp Ther 1999; 289: 721-8.
- 44 McNicol A, Nickolaychuk BR. Inhibition of collagen-induced platelet activation by arachidonyl trifluoromethyl ketone. Biochem Pharmacol 1995; 50: 1795-802.
- 45 Rittenhouse SE, Allen CL. Synergistic activation by collagen and 15-hydroxy-9 alpha,11 alpha-peroxidoprosta-5,13-dienoic acid (PGH2) of phosphatidyl inositol metabolism and arachidonic acid release in human platelets. J Clin Invest 1982; 70: 1216-24.
- 46 Sano K, Takai Y, Yamanishi J, Nishizuka Y. A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. J Biol Chem 1983; 258: 2010-3.
- 47 Vedelago HR, Mahadevappa VG. Mobilization of arachidonic acid in collagen-stimulated human platelets. Biochem J 1988; 256: 981-7.
- 48 Krishnamurthi S, Joseph S, Kakkar VV. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Biochim Biophys Acta 1987; 927: 429-36.
- 49 MacIntyre DE, McNicol A, Drummond AH. Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca2+ flux in human platelets. FEBS Lett 1985; 180: 160-4.
- 50 Watson SP. Lapetina EG 1,2-Diacylglycerol and phorbol ester inhibit agonist-induced formation of inositol phosphates in human platelets: possible implications for negative feedback regulation of inositol phospholipid hydrolysis. Proc Natl Acad Sci USA 1985; 82: 2623-6.
- 51 Siess W, Siegel FL, Lapetina EG. Arachidonic acid stimulates the formation of 1,2-diacylglycerol and phosphatidic acid in human platelets. Degree of phospholipase C activation correlates with protein phosphorylation, platelet shape change, serotonin release, and aggregation. J Biol Chem 1983; 258: 11236-42.
- 52 Pollock WK, Armstrong RA, Brydon LJ, Jones RL, MacIntyre DE. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium. Biochem J 1984; 219: 833-42.
- 53 Heemskerk JW, Farndale RW, Sage SO. Effects of U73122 and U73343 on human platelet calcium signalling and protein tyrosine phosphorylation. Biochim Biophys Acta 1997; 1355: 81-8.
- 54 Pulcinelli FM, Gresele P, Bonuglia M, Gazzaniga PP. Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets. Biochem Pharmacol 1998; 56: 1481-4.
- 55 Börsch-Haubold AG, Ghomashchi F, Pasquet S, Goedert M, Cohen P, Gelb MH, Watson SP. Phosphorylation of cytosolic phospholipase A2 in platelets is mediated by multiple stress-activated protein kinase pathways. Eur J Biochem 1999; 265: 195-203.
- 56 Kramer RM, Roberts EF, Um SL, Börsch-Haubold AG, Watson SP, Fisher MJ, Jakubowski JA. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2 . J Biol Chem 1996; 271: 27723-9.
- 57 Kramer RM, Roberts EF, Manetta JV, Sportsman JR, Jakubowski JA. Ca2+-sensitive cytosolic phospholipase A2 (cPLA2) in human platelets. J Lipid Mediat 1993; 6: 209-16.
- 58 Kramer RM, Roberts EF, Manetta JV, Hyslop PA, Jakubowski JA. Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets. J Biol Chem 1993; 268: 26796-804.
- 59 Börsch-Haubold AG, Bartoli F, Asselin J, Dudler T, Kramer RM, Apitz-Castro R, Watson SP, Gelb MH. Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J Biol Chem 1998; 273: 4449-58.
- 60 Bartoli F, Lin HK, Ghomashchi F, Gelb MH, Jain MK, Apitz-Castro R. Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem 1994; 269: 15625-30.
- 61 Riendeau D, Guay J, Weech PK, Laliberte F, Yergey J, Li C, Desmarais S, Perrier H, Liu S, Nicoll-Griffith D, Street IP. Arachidonyltrifluoro methyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosa-tetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem 1994; 269: 15619-24.
- 62 Bell RL, Kennerly DA, Stanford N, Majerus PW. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci USA 1979; 76: 3238-41.
- 63 Bell RL, Stanford N, Kennerly DA, Majerus PW. Diglyceride lipase: a pathway for arachidonate release from human platelets. Adv PG Tx Res 1980; 6: 219-24.
- 64 Rittenhouse-Simmons S. Indomethacin-induced accumulation of diglyce-ride in activated human platelets. The role of diglyceride lipase. J Biol Chem 1980; 255: 2259-62.
- 65 Takamura H, Narita H, Park HJ, Tanaka K, Matsuura T, Kito M. Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen. J Biol Chem 1987; 262: 2262-9.
- 66 Moriyama T, Wada K, Oki M, Matsuura T, Kito M. The mechanism of arachidonic acid release in collagen-activated human platelets. Biosci Biotechnol Biochem 1994; 58: 93-8.
- 67 Chau LY, Tai HH. Monoglyceride and diglyceride lipases from human platelet microsomes. Biochim Biophys Acta 1988; 963: 436-44.
- 68 McNicol A, Nickolaychuk BR, Israels SJ. The effects of inhibitors on collagen-induced platelet activation. Blood 1995; 85: 2177.